Advertisement
Screener

Benitec Biopharma Inc. (BNTC) Net Margin

Benitec Biopharma Inc. Net Margin

Net margin is the percentage of revenue a company keeps as profit after every expense and tax. It is net income divided by revenue, and the table shows both amounts beside the percentage. A higher net margin means more of each sales dollar reaches the bottom line. One-time gains, write-downs and tax items pass through net income, so a single period's net margin can move for reasons unrelated to the underlying business. Quarterly and annual points each use the amounts filed for that same period, so a single quarter can swing with the seasons.

  • Benitec Biopharma Inc. net margin for the quarter ending 2023-03-31 was -8142.59%, a change of -1319.68% year-over-year.
  • Benitec Biopharma Inc. net margin for the quarter ending 2022-12-31 was -38650.00%, a change of -19366.00% year-over-year.
  • Benitec Biopharma Inc. net margin for the quarter ending 2022-03-31 was -6822.92%, a change of 384077.08% year-over-year.
  • Benitec Biopharma Inc. net margin for the quarter ending 2021-12-31 was -19284.00%, a change of 305916.00% year-over-year.
  • Benitec Biopharma Inc. net margin for fiscal 2023 was -26082.67%, a change of -1140.20% from fiscal 2022.
  • Benitec Biopharma Inc. net margin for fiscal 2022 was -24942.47%, a change of -1413.65% from fiscal 2021.
  • Benitec Biopharma Inc. net margin for fiscal 2021 was -23528.81%, a change of -14998.92% from fiscal 2020.
  • Benitec Biopharma Inc. net margin for fiscal 2020 was -8529.90%, a 37864.98% decline from fiscal 2019.
Available history
2019-06-30 to 2023-06-30
Data captured

Historical Net Margin

DateNet MarginNet incomeRevenue
2023-03-31-8142.59%-$4.4M$54,000.00
2022-12-31-38650.00%-$5.41M$14,000.00
2022-03-31-6822.92%-$3.28M$48,000.00
2021-12-31-19284.00%-$4.82M$25,000.00
2021-06-30-200150.00%-$4M$2,000.00
2021-03-31-390900.00%-$3.91M$1,000.00
2020-12-31-325200.00%-$3.25M$1,000.00
2020-09-30-4941.82%-$2.72M$55,000.00
2020-06-308385.71%-$2.94M-$35,000.00
2020-03-31-7507.14%-$2.1M$28,000.00
2019-12-31-2714.29%-$2.09M$77,000.00
2019-09-30-3475.76%-$1.15M$33,000.00

Annual Net Margin

DateNet MarginNet incomeRevenue
2023-06-30-26082.67%-$19.56M$75,000.00
2022-06-30-24942.47%-$18.21M$73,000.00
2021-06-30-23528.81%-$13.88M$59,000.00
2020-06-30-8529.90%-$8.27M$97,000.00
2019-06-3022.59%$2.61M$11.55M

Similar stocks

Stock NameCountryMarket CapPE Ratio
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
Emergent BioSolutions Inc. (EBS)United States$0.347B-2.43
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Vogenx, Inc. (VOGX)United States$0.355B
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58